Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 18, 2013

Drug Name	Review Type	Class	Manufacturer
Abilify Maintena	New Drug Initial Review	Atypical Antipsychotic	Otsuka America
Zubsolv	New Drug Initial Review	Narcotic	Orexo
Tivicay	New Drug Initial Review	HIV antiretroviral	ViiV Healthcare
Linzess	New Drug Initial Review	Guanylate cyclase-C agonist	Forest
Tecfidera	New Drug Appeal	Multiple Sclerosis	Biogen Idec
Avonex	PDL Appeal	Multiple Sclerosis	Biogen Idec
TrueResult/TrueTrack	PDL Appeal	Diabetes	Nipro Diagnostics
Dulera	PDL Appeal	Inhaled Corticosteroid	Merck
Advair Diskus	PDL Appeal	ICS/LABA	GlaxoSmithKline

Footer